Juvéderm family guides, comparisons, product selection, longevity, cost, and filler risk.
US Belotero duration is PMA- and area-specific. Healthline mixes EU SKUs. Intense P250016 is lips, not EU deep folds. Volume is 48-week cheeks versus Lyft, not Voluma's…
RHA duration is PMA- and area-specific. Manufacturer up-to-15-months is a 64-week NLF follow-up, not a median. Dynamic Volume midface is S048 18 Sep 2025, not the 13 Jan…
How long Restylane lasts is product- and area-specific PMA data. Manufacturer up-to numbers are ceilings with touch-up, not medians. Contour is not Lyft.
How long Juvéderm lasts is product- and area-specific PMA data. Manufacturer up-to numbers are ceilings with touch-up, not medians. Volbella is not Vollure.
FDA approved RHA Redensity Eye on 12 May 2026 for infraorbital hollows. It is a 15 mg/g gel, the fourth on-label HA, not the first under-eye filler.
Skinvive by Juvéderm gained a US neck-lines indication on 11 June 2026 (P110033/S099). What the PMA actually covers, which trial counts, duration, cost, and what still…
Which hyaluronic-acid fillers are actually FDA-approved for the chin, how they differ from Volux jawline filler, and when an implant or Kybella is the better next step.
Sunken temples can age the upper face, but vascular safety is critical. We analyze Juvéderm Voluma, Restylane Contour, off-label biostimulators, and FDA MAUDE safety…
A clinical and economic guide comparing dermal fillers, Sculptra, fat transfer, and malar implants for midface volume restoration, featuring ASPS data and FDA approval…
A comprehensive regulatory dossier analyzing AbbVie/Allergan Aesthetics' approvals, BIOCELL textured breast implant recalls, and CoolSculpting and Juvéderm adverse…